GENE ONLINE|News &
Opinion
Blog

EMA
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
AstraZeneca’s COVID-19 Vaccine Finally Wins Full Authorization in the European Union
2022-11-01
EMA Upholds Recommendation For Withdrawing Marketing Authorization for Amfepramone Obesity Medicines
2022-10-28
AbbVie and Genmab’s Joint Cancer Treatment Receives EMA Validation
2022-10-28
Atara, Pierre Fabre’s EBV T-Cell Therapy Recommended For Approval In Europe
2022-10-17
EMA Signals Positive Opinion for Regeneron’s Cervical Cancer Monotherapy
2022-10-14
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
Merck’s Vaccine For Streptococcus Pneumoniae Lined Up for Another European Commission Approval
2022-09-16
BioCryst’s ALK-2 Inhibitor Granted FDA Orphan Drug Status For Rare Bone Disease
2022-09-01
EMA Accepts Daiichi Sankyo’s Marketing Application For Leukemia Drug
2022-08-24
EMA Announces Advice on Switch that Could Increase The Monkeypox Vaccine Supply
2022-08-19
EMA Begins Review of SK biosciences’ New Non-mRNA COVID-19 vaccine
2022-08-18
Applications for Medicine Treating Crohn’s Disease Submitted to EMA and FDA
2022-07-29
EMA Responds to Monkeypox Public Health Emergency
2022-07-28
1 2
LATEST
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Comparing ESG Regulations in the U.S., the U.K., and the EU
2023-03-21
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
2023-03-21
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Scroll to Top